93 related articles for article (PubMed ID: 3201902)
1. Erythropoietic changes in chronic hemodialysis patients undergoing recombinant human erythropoietin therapy.
Yoshida Y; Ohmori S; Tohyama K; Uchino H; Sawanishi K; Itoh M; Sohma T; Kuze M
Nihon Ketsueki Gakkai Zasshi; 1988 Sep; 51(6):1092-6. PubMed ID: 3201902
[No Abstract] [Full Text] [Related]
2. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
von Appen K; Klinkmann H
Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
[No Abstract] [Full Text] [Related]
3. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
Eschbach JW; Haley NR; Adamson JW
Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841
[No Abstract] [Full Text] [Related]
4. [Effect of recombinant human erythropoietin on the bone marrow picture in patients with chronic renal failure treated by hemodialysis].
Sułowicz W; Hanicki Z; Skotnicki AB; Wójcik J; Sydor A
Przegl Lek; 1992; 49(3):88-90. PubMed ID: 1438902
[TBL] [Abstract][Full Text] [Related]
5. Correction of amino acid metabolism by recombinant human erythropoietin therapy in hemodialysis patients.
Riedel E; Hampl H; Scigalla P; Nündel M; Kessel M
Kidney Int Suppl; 1989 Nov; 27():S216-21. PubMed ID: 2636662
[TBL] [Abstract][Full Text] [Related]
6. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
7. Blood rheology in hemodialysis patients treated with recombinant human erythropoietin.
Brunner R; Pollok M; Heidel M; Müller R; Degenhardt S; Baldamus CA
Contrib Nephrol; 1989; 76():306-12; discussion 312-4. PubMed ID: 2582784
[No Abstract] [Full Text] [Related]
8. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
Ifudu O; Feldman J; Friedman EA
N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
[TBL] [Abstract][Full Text] [Related]
9. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
[TBL] [Abstract][Full Text] [Related]
10. Plasma erythropoietin levels in patients undergoing long-term hemodialysis.
Raich PC; Korst DR
Arch Pathol Lab Med; 1978 Feb; 102(2):73-5. PubMed ID: 579968
[TBL] [Abstract][Full Text] [Related]
11. Intensity of hemodialysis and response to erythropoietin.
Kotanko P
N Engl J Med; 1996 Jun; 334(25):1670; author reply 1670-1. PubMed ID: 8628371
[No Abstract] [Full Text] [Related]
12. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
Kotaki M; Uday K; Henriquez M; Blum S; Dave M
Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
[No Abstract] [Full Text] [Related]
13. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
Korbet SM
Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832
[No Abstract] [Full Text] [Related]
14. [Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients].
Ueyama H; Nakahashi H; Sawanishi K; Kuze M; Ono T
Hinyokika Kiyo; 1992 Dec; 38(12):1429-35. PubMed ID: 1288237
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow amyloidosis with erythropoietin-resistant anemia in a patient undergoing chronic hemodialysis treatment.
Cetinkaya R; Odabas AR; Selcuk Y; Erman Z; Kaya H
South Med J; 2003 May; 96(5):491-3. PubMed ID: 12911189
[TBL] [Abstract][Full Text] [Related]
16. A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis.
Berns JS; Rudnick MR; Cohen RM
Clin Nephrol; 1992 May; 37(5):264-7. PubMed ID: 1606777
[TBL] [Abstract][Full Text] [Related]
17. [Use of human recombinant erythropoietin (rHuEPO) for treatment of anemia in patients with chronic kidney failure who don't require additional dialysis therapy].
Wiecek A
Przegl Lek; 1995; 52(3):93-4. PubMed ID: 7644683
[No Abstract] [Full Text] [Related]
18. Effects of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo.
Hino M; Miyazono K; Urabe A; Takaku F
Int J Cell Cloning; 1989 Jul; 7(4):257-63. PubMed ID: 2768843
[TBL] [Abstract][Full Text] [Related]
19. [The recovery of erythropoiesis after the short-term Recormon treatment of renal anemia].
Nikolaev AIu; Klepikov PV; Lashutin SV
Ter Arkh; 1992; 64(6):90-1. PubMed ID: 1440349
[No Abstract] [Full Text] [Related]
20. [Recent findings on the pathogenesis and therapy of anemia in chronic kidney failure].
Moccia F; Morra L; Gurreri G
Recenti Prog Med; 1992 Oct; 83(10):572-6. PubMed ID: 1462041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
